Daewoong Pharmaceutical Co., Ltd. (069620) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 92 PAGES: 33

More Info
									          Daewoong Pharmaceutical Co., Ltd. (069620) - Financial and Strategic
                             SWOT Analysis Review
        Reference Code: GDPH28666FSA                                                                                          Publication Date: MAR 2013

                                                                                                                                 710,547.15          (million
          (135-715) 163-3, Samsung-dong                      Phone              +82 2 5508800                   Revenue
                                                                                                                                 KRW)
                                                                                                                                 34,079.29           (million
          Seoul, Gangnam-gu                                  Fax                +82 2 5508400                   Net Profit
                                                                                                                                 KRW)
          462120                                             Website            www.daewoong.com                Employees        1,389
                                                                                069620 [Korea        Stock                       Pharmaceuticals           &
          Republic of Korea                                  Exchange                                           Industry
                                                                                Exchange]                                        Healthcare

       Company Overview
       Daewoong Pharmaceutical Co., Ltd. (Daewoong Pharma) is a Korean based drug manufacturing and distribution company. It is
       the leading prescription drugs saling company in Korea. The company's product offering consists of drugs in the forms of tabs,
       capsules, ointments, injections, liquids and sprays. Daewoong Pharma offers its products for the therapeutic conditions of bone
       and joint diseases, cardiovascular treatments, central nervous system treatments, circulatory system agents, dermatologic
       agents, gastrointestinal agents, health supplements, respiratory remedies and others.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Daewoong Pharmaceutical Co., Ltd., SWOT Analysis
         Jae Hun Yoon                        Chief Executive Officer                  Strengths                              Weaknesses
         Jong Wuk Lee                        Chief Executive Officer
                                                                                      Broad Product Portfolio                Weak Operational Efficiency
         Yeong Hwan Yoon                     Chairman
                                                                                      Strong Research and
         Jae Seung Yoon                      Vice Chairman
                                                                                      Development Capabilities
         Joon Pio Hong                       Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Market Potential: Oncology             Increased Drug Scrutiny
         Daewoong Pharmaceutical Co., Ltd.
                                                                                      Product Launches                       Uncertain R&D Outcome
        Share Price (KRW) as on 08-                                   55,200
        Mar-2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (KRW)                                                  3,401.04          GlobalData
        Market Cap (million KRW)                                    553,119
        Enterprise Value (million KRW)                              508,763
        Shares Outstanding (million)                                       10
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Daewoong Pharmaceutical Co., Ltd. (069620) - Financial and                                                                     Reference Code: GDPH28666FSA
Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                      Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Daewoong Pharmaceutical Co., Ltd. - Key Facts ............................................................................................................................... 4
       Daewoong Pharmaceutical Co., Ltd. - Key Employees ...................................................................................................................... 5
       Daewoong Pharmaceutical Co., Ltd. - Major Products and Services ................................................................................................. 6
       Daewoong Pharmaceutical Co., Ltd. - Pharmaceutical Pipeline Products Data ................................................................................. 8
          Daewoong Pharmaceutical Co., Ltd., Pipeline Products by Therapy Area ..................................................................................... 8
          Daewoong Pharmaceutical Co., Ltd., Pipeline Products by Development Phase ........................................................................... 9
       Daewoong Pharmaceutical Co., Ltd. - History .................................................................................................................................. 11
       Daewoong Pharmaceutical Co., Ltd. - Company Statement ............................................................................................................ 14
       Daewoong Pharmaceutical Co., Ltd. - Locations And Subsidiaries .................................................................................................. 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
          Affiliate .......................................................................................................................................................................................... 16
       Section 2 – Company Analysis ......................................................................................................................................................... 17
       Daewoong Pharmaceutical Co., Ltd. - Business Description............................................................................................................ 17
       Daewoong Pharmaceutical Co., Ltd. - SWOT Analysis .................................................................................................................... 18
          SWOT Analysis - Overview........................................................................................................................................................... 18
          Daewoong Pharmaceutical Co., Ltd. - Strengths .......................................................................................................................... 18
             Strength - Broad Product Portfolio ............................................................................................................................................ 18
             Strength - Strong Research and Development Capabilities ...................................................................................................... 18
             Strength - Partnerships and Collaborations............................................................................................................................... 18
          Daewoong Pharmaceutical Co., Ltd. - Weaknesses ..................................................................................................................... 18
             Weakness - Weak Operational Efficiency ................................................................................................................................. 18
          Daewoong Pharmaceutical Co., Ltd. - Opportunities .................................................................................................................... 19
             Opportunity - Market Potential: Oncology.................................................................................................................................. 19
             Opportunity - Product Launches ................................................................................................................................................ 19
             Opportunity - Strategic Agreements .......................................................................................................................................... 19
          Daewoong Pharmaceutical Co., Ltd. - Threats ............................................................................................................................. 19
             Threat - Increased Drug Scrutiny .............................................................................................................................................. 19
             Threat - Uncertain R&D Outcome ............................................................................................................................................. 20
             Threat - Inherent Factor ............................................................................................................................................................ 20
       Daewoong Pharmaceutical Co., Ltd. - Key Competitors .................................................................................................................. 21
       Section 3 – Company Financial Ratios ............................................................................................................................................. 22
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 22
       Fin
								
To top